CHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 9 | 2011 | 11067 | 11769 | 94.0% | |
| CHD 9 | 2012 | 10979 | 11732 | 93.6% | |
| CHD 9 | 2013 | 10946 | 11720 | 93.4% | |
| CHD005 | 2014 | 10665 | 11205 | 95.2% | |
| CHD005 | 2015 | 10585 | 11147 | 95.0% | |
| CHD005 | 2016 | 10677 | 11235 | 95.0% | |
| CHD005 | 2017 | 10652 | 11188 | 95.2% | |
| CHD005 | 2018 | 10617 | 11048 | 96.1% | |
| CHD005 | 2019 | 10477 | 10975 | 95.5% | |
| CHD005 | 2020 | 10440 | 10965 | 95.2% | |
| CHD005 | 2021 | 10036 | 10948 | 91.7% | |
| CHD005 | 2022 | 10086 | 10625 | 94.9% | |
| CHD005 | 2023 | 10012 | 10370 | 96.5% |
